Kadir Serkan Orhan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kadir Serkan Orhan has a total of 182 co-authors. Here are the top co-authors by number of shared publications:
- Mehmet Çelik
Department of Otorhinolaryngology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
16 shared publications - Beldan Polat
Istanbul Faculty of Medicine, Department of Otorhinolaryngology, Istanbul University, Istanbul, Turkey
15 shared publications - Said Sönmez
Istanbul University
14 shared publications Yahya Güldiken
Istanbul Faculty of Medicine, Department of Otorhinolaryngology, Istanbul University
6 shared publications- Yahya Güldiken
Istanbul Faculty of Medicine, Department of Otorhinolaryngology, Istanbul University, Istanbul, Turkey
6 shared publications - Elif Kocasoy Orhan
Department of Neurology, Faculty of Medicine, Istanbul University, Istanbul, Türkiye
5 shared publications
Latest Publications
- 19 July 2026
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 283 (10) , 6425-6431
Extent of facial nerve decompression at the geniculate ganglion and labyrinthine segment via transmastoid supralabyrinthine approach: cadaveric study
Objective To quantitatively assess the extent of facial nerve decompression achievable at thegeniculate ganglion and labyrinthine segment using the transmastoid supralabyrinthineapproach in cadaveric specimens. Methods Eleven formalin-fixed human cadaveric heads (22 temporal bones) underwentpreoperative high-resolution computed tomography (CT) to measure the lengths of thegeniculate ganglion and labyrinthine segment within their bony canals. A standardizedtransmastoid supralabyrinthine approach was then performed to decompress the facialnerve. Postoperative CT was used to determine the length of nerve segments successfully decompressed. Pre- and postoperative measurements were compared tocalculate the percentage of decompression achieved. Results Complete exposure of the geniculate ganglion was achieved in all specimens. Themean total length of the labyrinthine segment was 3.28 ± 0.80 mm. Followingdecompression, a mean length of 1.37 ± 0.84 mm of the labyrinthine segment wassuccessfully unroofed, corresponding to an average decompression of 40 ± 22%. Noinjury to the ossicular chain, semicircular canals, or labyrinth was observed onpostoperative CT imaging. Conclusion The transmastoid supralabyrinthine approach enables safe, hearing-preservingdecompression of the geniculate ganglion and partial decompression of thelabyrinthine segment. Despite limited exposure of the labyrinthine segment, it mayserve as a feasible alternative in selected cases where more extensive approachesentail higher morbidity.
- 19 July 2026
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 283 (10) , 6425-6431
Extent of facial nerve decompression at the geniculate ganglion and labyrinthine segment via transmastoid supralabyrinthine approach: cadaveric study
Objective To quantitatively assess the extent of facial nerve decompression achievable at thegeniculate ganglion and labyrinthine segment using the transmastoid supralabyrinthineapproach in cadaveric specimens. Methods Eleven formalin-fixed human cadaveric heads (22 temporal bones) underwentpreoperative high-resolution computed tomography (CT) to measure the lengths of thegeniculate ganglion and labyrinthine segment within their bony canals. A standardizedtransmastoid supralabyrinthine approach was then performed to decompress the facialnerve. Postoperative CT was used to determine the length of nerve segments successfully decompressed. Pre- and postoperative measurements were compared tocalculate the percentage of decompression achieved. Results Complete exposure of the geniculate ganglion was achieved in all specimens. Themean total length of the labyrinthine segment was 3.28 ± 0.80 mm. Followingdecompression, a mean length of 1.37 ± 0.84 mm of the labyrinthine segment wassuccessfully unroofed, corresponding to an average decompression of 40 ± 22%. Noinjury to the ossicular chain, semicircular canals, or labyrinth was observed onpostoperative CT imaging. Conclusion The transmastoid supralabyrinthine approach enables safe, hearing-preservingdecompression of the geniculate ganglion and partial decompression of thelabyrinthine segment. Despite limited exposure of the labyrinthine segment, it mayserve as a feasible alternative in selected cases where more extensive approachesentail higher morbidity.
- 15 May 2026
- Vol. 53 (4) , 485-492
Analysis of indications, intraoperative findings, and audiologic outcomes of pure endoscopic revision stapes surgery: A multicenter study.
This retrospective multicenter study aims to provide a comprehensive analysis of the causes of revision and audiologic outcomes in cases that underwent revision stapes surgery (SS) a pure endoscopic transcanal approach over 10 years. This study analyses the outcomes of patients who underwent exclusive endoscopic revision SS between January 2015 and March 2025. These cases were either the authors' own cases or cases referred from other centers for the management of SS complications, as well. A total of 113 patients (42 males (37.2%), 71 females (62.8%), with an average age of 40.4 ± 8.6 years, age range: 10-68, who had previously undergone SS and underwent revision SS were included in the study. The most common intraoperative findings were prosthesis-related troubleshoots (prosthesis being too short (n = 41, 36.3%) or too long (n = 21, 18.6%), prosthesis dislocation from incus: 38 (33.6%)) and incus long process (ILP) necrosis (n = 33, 29.2%). After endoscopic revision SS, the average pre-op ABG value of 29.8 ± 10.1 dB improved to 13.7 ± 5.2 dB postoperatively (p < 0.001). 75.2% (85/113) of patients achieved post-op ABG values below 20 dB. The need for revision in SS depends on various factors, including the surgeon, the patient, and prosthesis-related issues. Endoscopes are advanced diagnostic and surgical tools that provide high-resolution, dynamic and panoramic images of the entire middle ear structures, enabling accurate diagnosis of the problem. The endoscopes permit the surgeon to perform revision SS with a high degree of precision through a purely transcanal approach, thereby achieving audiological outcomes that are consistent with the range of reports in the literature for conventional microscopic revision SS.
- 15 May 2026
- Vol. 53 (4) , 485-492
Analysis of indications, intraoperative findings, and audiologic outcomes of pure endoscopic revision stapes surgery: A multicenter study.
This retrospective multicenter study aims to provide a comprehensive analysis of the causes of revision and audiologic outcomes in cases that underwent revision stapes surgery (SS) a pure endoscopic transcanal approach over 10 years. This study analyses the outcomes of patients who underwent exclusive endoscopic revision SS between January 2015 and March 2025. These cases were either the authors' own cases or cases referred from other centers for the management of SS complications, as well. A total of 113 patients (42 males (37.2%), 71 females (62.8%), with an average age of 40.4 ± 8.6 years, age range: 10-68, who had previously undergone SS and underwent revision SS were included in the study. The most common intraoperative findings were prosthesis-related troubleshoots (prosthesis being too short (n = 41, 36.3%) or too long (n = 21, 18.6%), prosthesis dislocation from incus: 38 (33.6%)) and incus long process (ILP) necrosis (n = 33, 29.2%). After endoscopic revision SS, the average pre-op ABG value of 29.8 ± 10.1 dB improved to 13.7 ± 5.2 dB postoperatively (p < 0.001). 75.2% (85/113) of patients achieved post-op ABG values below 20 dB. The need for revision in SS depends on various factors, including the surgeon, the patient, and prosthesis-related issues. Endoscopes are advanced diagnostic and surgical tools that provide high-resolution, dynamic and panoramic images of the entire middle ear structures, enabling accurate diagnosis of the problem. The endoscopes permit the surgeon to perform revision SS with a high degree of precision through a purely transcanal approach, thereby achieving audiological outcomes that are consistent with the range of reports in the literature for conventional microscopic revision SS.
- Open Access
- 27 February 2026
- Published by AVES YAYINCILIK A.Ş. in Balkan ORL-HNS
- Vol. 3 (1) , 1-5
Long-Term Glasgow Benefit Inventory Outcomes in Patients Using Transcutaneous versus Percutaneous Bone-Anchored Hearing Devices
Background: To compare patient-reported outcomes following percutaneous and transcutaneous bone-anchored hearing aid (BAHA) implantation using the Glasgow Benefit Inventory (GBI). Methods: This retrospective study included patients who underwent BAHA implantation at a tertiary university center between 2011 and 2023, with a median follow-up of 95.50 months [IQR: 37.00-132.00] (range, 16-158 months). Patient-reported outcomes were assessed using the validated GBI, which evaluates general benefit, social benefit, physical health, and a total score. Glasgow Benefit Inventory scores were compared between percutaneous and transcutaneous BAHA users. Owing to the limited number of patients, the softband group was evaluated descriptively only. Statistical analyses were performed using the Mann–Whitney U-test. Results: A total of 46 patients were included: 33 transcutaneous and 13 percutaneous BAHA users. The general benefit score was significantly higher in the percutaneous group than in the transcutaneous group (median [IQR]: 83.34 [37.50-89.58] vs. 41.67 [20.83-70.83], P = .032). Total GBI scores were numerically higher in the percutaneous group; however, the difference did not reach statistical significance (P = .069). No statistically significant differences were observed between groups in terms of social benefit (P = .157) or physical health (P = .502). Conclusion: Both percutaneous and transcutaneous BAHA implantation provided meaningful patient-reported benefit. Percutaneous BAHA was associated with a significantly higher general benefit score, while total, social, and physical health benefits were comparable between techniques. These findings emphasize the importance of long-term follow-up and individualized device selection. Cite this article as: Sönmez S, Orak Ö, Güldiken Y, et al. Long-term glasgow benefit inventory outcomes in patients using transcutaneous versus percutaneous bone-anchored hearing devices. Balkan ORL-HNS. 2026, 3, 0135, 10.5152/bohns.2026.25135.
- 27 February 2026
- Published by AVES YAYINCILIK A.Ş. in Balkan ORL-HNS
- Vol. 3 (1) , 1-5
Open AccessLong-Term Glasgow Benefit Inventory Outcomes in Patients Using Transcutaneous versus Percutaneous Bone-Anchored Hearing Devices
Background: To compare patient-reported outcomes following percutaneous and transcutaneous bone-anchored hearing aid (BAHA) implantation using the Glasgow Benefit Inventory (GBI). Methods: This retrospective study included patients who underwent BAHA implantation at a tertiary university center between 2011 and 2023, with a median follow-up of 95.50 months [IQR: 37.00-132.00] (range, 16-158 months). Patient-reported outcomes were assessed using the validated GBI, which evaluates general benefit, social benefit, physical health, and a total score. Glasgow Benefit Inventory scores were compared between percutaneous and transcutaneous BAHA users. Owing to the limited number of patients, the softband group was evaluated descriptively only. Statistical analyses were performed using the Mann–Whitney U-test. Results: A total of 46 patients were included: 33 transcutaneous and 13 percutaneous BAHA users. The general benefit score was significantly higher in the percutaneous group than in the transcutaneous group (median [IQR]: 83.34 [37.50-89.58] vs. 41.67 [20.83-70.83], P = .032). Total GBI scores were numerically higher in the percutaneous group; however, the difference did not reach statistical significance (P = .069). No statistically significant differences were observed between groups in terms of social benefit (P = .157) or physical health (P = .502). Conclusion: Both percutaneous and transcutaneous BAHA implantation provided meaningful patient-reported benefit. Percutaneous BAHA was associated with a significantly higher general benefit score, while total, social, and physical health benefits were comparable between techniques. These findings emphasize the importance of long-term follow-up and individualized device selection. Cite this article as: Sönmez S, Orak Ö, Güldiken Y, et al. Long-term glasgow benefit inventory outcomes in patients using transcutaneous versus percutaneous bone-anchored hearing devices. Balkan ORL-HNS. 2026, 3, 0135, 10.5152/bohns.2026.25135.
- 27 February 2026
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 146 (3) , 272-277
A novel surgical technique in pediatric simultaneous bilateral cochlear implantation
Cochlear implantation (CI) is the standard of care for children with bilateral severe-to-profound sensorineural hearing loss, particularly when performed at an early age to optimize auditory and la...
- 27 February 2026
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 146 (3) , 272-277
A novel surgical technique in pediatric simultaneous bilateral cochlear implantation
Cochlear implantation (CI) is the standard of care for children with bilateral severe-to-profound sensorineural hearing loss, particularly when performed at an early age to optimize auditory and la...
- Open Access
- 23 February 2026
- Published by AVES YAYINCILIK A.Ş. in B-ENT
- Vol. 21 (2) , 91-96
Malignant Otitis Externa: Clinical Management, Comprehensive Review, and Long-Term Outcomes
Background: Malignant otitis externa (MOE) is a severe, life-threatening infection that primarily affects elderly and immunocompromised individuals, particularly those with diabetes mellitus. This study provides a comprehensive analysis of clinical features, diagnostic methods, management strategies, and long-term outcomes of MOE patients at a tertiary care center. Methods: The retrospective study included 31 adult patients diagnosed with MOE between 2009 and 2020. Data on demographics, comorbidities, symptoms, examination findings, laboratory parameters, imaging, microbiological cultures, treatments, and surgeries were systematically analyzed. Patients with incomplete follow-up or data were excluded. Results: The mean age was 69.5 ± 10.9 years, with 64.5% male predominance. Diabetes was the most common comorbidity (96.8%), followed by hematological malignancies, chronic renal failure, and hypertension. Persistent otalgia (100%) and otorrhea (93.5%) were the leading symptoms. Physical exams revealed granulation tissue (70.9%), canal edema (77.4%), and exposed bone tissue (6.5%). Facial nerve palsy occurred in 48.4% of cases, with other cranial nerve involvement in 9.7%. Microbiological cultures predominantly identified Pseudomonas aeruginosa (58.1%), Staphylococcus aureus, and fungal pathogens, with 16.1% culture-negative cases. Imaging, especially technetium and gallium scintigraphy, aided diagnosis and monitoring. All patients received culture-directed antibiotics, with a mean hospitalization of 45.06 ± 19.27 days. Surgical interventions were needed in 48.4% of patients, primarily for advanced disease or treatment failure. Post-treatment, hemoglobin A1c levels decreased from 7.50 ± 1.21 to 6.26 ± 0.72, and erythrocyte sedimentation rate values improved significantly. The mean follow-up was 66.29 ± 48.14 months, with no in-hospital mortality. Conclusion: Malignant otitis externa presents diagnostic and therapeutic challenges, especially in high-risk groups. Early detection, advanced imaging, and a multidisciplinary approach are vital for effective management. Surgical intervention is a crucial option for refractory cases. It is believed that the data from this study will contribute to guidelines that will be developed to improve diagnostic criteria, establish standard treatment protocols, and improve patient outcomes. Cite this article as: S.nmez S, Kara H, Benli A, et al. Malignant otitis externa: clinical management, comprehensive review, and long-term outcomes. B-ENT. 2025;21(2):91-96.
- 23 February 2026
- Published by AVES YAYINCILIK A.Ş. in B-ENT
- Vol. 21 (2) , 91-96
Open AccessMalignant Otitis Externa: Clinical Management, Comprehensive Review, and Long-Term Outcomes
Background: Malignant otitis externa (MOE) is a severe, life-threatening infection that primarily affects elderly and immunocompromised individuals, particularly those with diabetes mellitus. This study provides a comprehensive analysis of clinical features, diagnostic methods, management strategies, and long-term outcomes of MOE patients at a tertiary care center. Methods: The retrospective study included 31 adult patients diagnosed with MOE between 2009 and 2020. Data on demographics, comorbidities, symptoms, examination findings, laboratory parameters, imaging, microbiological cultures, treatments, and surgeries were systematically analyzed. Patients with incomplete follow-up or data were excluded. Results: The mean age was 69.5 ± 10.9 years, with 64.5% male predominance. Diabetes was the most common comorbidity (96.8%), followed by hematological malignancies, chronic renal failure, and hypertension. Persistent otalgia (100%) and otorrhea (93.5%) were the leading symptoms. Physical exams revealed granulation tissue (70.9%), canal edema (77.4%), and exposed bone tissue (6.5%). Facial nerve palsy occurred in 48.4% of cases, with other cranial nerve involvement in 9.7%. Microbiological cultures predominantly identified Pseudomonas aeruginosa (58.1%), Staphylococcus aureus, and fungal pathogens, with 16.1% culture-negative cases. Imaging, especially technetium and gallium scintigraphy, aided diagnosis and monitoring. All patients received culture-directed antibiotics, with a mean hospitalization of 45.06 ± 19.27 days. Surgical interventions were needed in 48.4% of patients, primarily for advanced disease or treatment failure. Post-treatment, hemoglobin A1c levels decreased from 7.50 ± 1.21 to 6.26 ± 0.72, and erythrocyte sedimentation rate values improved significantly. The mean follow-up was 66.29 ± 48.14 months, with no in-hospital mortality. Conclusion: Malignant otitis externa presents diagnostic and therapeutic challenges, especially in high-risk groups. Early detection, advanced imaging, and a multidisciplinary approach are vital for effective management. Surgical intervention is a crucial option for refractory cases. It is believed that the data from this study will contribute to guidelines that will be developed to improve diagnostic criteria, establish standard treatment protocols, and improve patient outcomes. Cite this article as: S.nmez S, Kara H, Benli A, et al. Malignant otitis externa: clinical management, comprehensive review, and long-term outcomes. B-ENT. 2025;21(2):91-96.
- 8 January 2026
- Published by Elsevier in Auris Nasus Larynx
- Vol. 53 (1) , 137-145
Evaluation of ear structures on fetal MRI: A comparative analysis at 1.5-T and 3-T
- 8 January 2026
- Published by Elsevier in Auris Nasus Larynx
- Vol. 53 (1) , 137-145
Evaluation of ear structures on fetal MRI: A comparative analysis at 1.5-T and 3-T
- 1 October 2025
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 283 (2) , 691-699
An exclusive endoscopic transcanal treatment of congenital cholesteatoma: A multi-institutional study
Purpose To present surgical and audiological outcomes of the pure endoscopic transcanal approach in the treatment of congenital cholesteatoma (CC). Methods The present retrospective multicentre study included 34 patients who underwent exclusive transcanal endoscopic ear surgery (ETEES) for CC treatment by senior surgeons with expertise in endoscopic ear surgery. The extent of the CC was classified according to the Potsic stage. A comprehensive investigation was conducted, encompassing a multitude of parameters, including patients’ demographics, CC characteristics, ossicular chain status, ossiculoplasty techniques, operative time, complications, residual or recurrent cholesteatoma, and audiological outcomes. Results Of the 34 CC patients enrolled in the study, 19 (55.9%) were male and 15 (44.1%) were female; their mean age was 15.2 ± 6.1 years, and their average follow-up period was 36.4 ± 10.2 months. There were 11 cases (32.4%) of Potsic stage I CC, 7 (20.6%) stage II, 10 (29.4%) stage III, and 6 (17.6%) stage IV. The average operating time was 86.2 ± 16.9 min (ranging 40–180 min). Overall, 9 (26.5%) patients underwent a second-look and revision surgery via ETEES approach, due to conductive hearing loss and recurrence, in 4 (11.8%) cases with Potsic stage III and in 2 (5.8%) cases with Potsic stage IV iatrogenic and residual CC were observed. The preoperative air-bone gap (ABG) values demonstrated a notable postoperative improvement, declining from a mean of 31.4 ± 8.1 dB preoperatively to 13.5 ± 3.6 dB (p < 0.001). Conclusion ETEES, with the advantage of being able to visualize concealed areas of the middle ear with minimal bone work, is a feasible, safe, and effective surgical technique in the treatment of CC, even when CC extends into the mastoid, offering comparable audiological outcomes with lower recurrence ratios relative to conventional surgical techniques present in the current literature.
- 1 October 2025
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 283 (2) , 691-699
An exclusive endoscopic transcanal treatment of congenital cholesteatoma: A multi-institutional study
Purpose To present surgical and audiological outcomes of the pure endoscopic transcanal approach in the treatment of congenital cholesteatoma (CC). Methods The present retrospective multicentre study included 34 patients who underwent exclusive transcanal endoscopic ear surgery (ETEES) for CC treatment by senior surgeons with expertise in endoscopic ear surgery. The extent of the CC was classified according to the Potsic stage. A comprehensive investigation was conducted, encompassing a multitude of parameters, including patients’ demographics, CC characteristics, ossicular chain status, ossiculoplasty techniques, operative time, complications, residual or recurrent cholesteatoma, and audiological outcomes. Results Of the 34 CC patients enrolled in the study, 19 (55.9%) were male and 15 (44.1%) were female; their mean age was 15.2 ± 6.1 years, and their average follow-up period was 36.4 ± 10.2 months. There were 11 cases (32.4%) of Potsic stage I CC, 7 (20.6%) stage II, 10 (29.4%) stage III, and 6 (17.6%) stage IV. The average operating time was 86.2 ± 16.9 min (ranging 40–180 min). Overall, 9 (26.5%) patients underwent a second-look and revision surgery via ETEES approach, due to conductive hearing loss and recurrence, in 4 (11.8%) cases with Potsic stage III and in 2 (5.8%) cases with Potsic stage IV iatrogenic and residual CC were observed. The preoperative air-bone gap (ABG) values demonstrated a notable postoperative improvement, declining from a mean of 31.4 ± 8.1 dB preoperatively to 13.5 ± 3.6 dB (p < 0.001). Conclusion ETEES, with the advantage of being able to visualize concealed areas of the middle ear with minimal bone work, is a feasible, safe, and effective surgical technique in the treatment of CC, even when CC extends into the mastoid, offering comparable audiological outcomes with lower recurrence ratios relative to conventional surgical techniques present in the current literature.
- Open Access
- 22 August 2025
- Published by Galenos Yayinevi in Turkish Archives of Otorhinolaryngology
- Vol. 63 (3) , 113-120
Investigation of the Effects of the Timing of Decompression and Topical Mitomycin-C Application on Nerve Regeneration in a Rat Model of Bell’s Palsy
Investigation of the Effects of the Timing of Decompression and Topical Mitomycin-C Application on Nerve Regeneration in a Rat Model of Bell’s Palsy - Turkish Archives of Otorhinolaryngology
- 22 August 2025
- Published by Galenos Yayinevi in Turkish Archives of Otorhinolaryngology
- Vol. 63 (3) , 113-120
Open AccessInvestigation of the Effects of the Timing of Decompression and Topical Mitomycin-C Application on Nerve Regeneration in a Rat Model of Bell’s Palsy
Investigation of the Effects of the Timing of Decompression and Topical Mitomycin-C Application on Nerve Regeneration in a Rat Model of Bell’s Palsy - Turkish Archives of Otorhinolaryngology
- Open Access
- 9 July 2025
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 21 (2) , 1-6
Proceedings of the Round Table Discussion on the Fifth International Symposium on Otosclerosis and Stapes Surgery
Background: Debates and research about otosclerosis and stapes surgery have continued since the time it was described, and there is still no consensus on many issues. The aim of this article is to report the controversies in the etiology, pathophysiology, diagnosis, imaging, treatment, and management of otosclerosis and address the points of consensus of experts.Methods: In the last session of the Fifth International Otosclerosis and Stapes Surgery Symposium held in Brussels, a round table meeting was held where controversial issues in otosclerosis and stapes surgery were discussed, and a survey was administered to all participants. Nine experienced panelists were interviewed by the moderator on stage, and 166 participants provided their answers interactively through the online voting system.Results: All of the panelists were experts in their field who had performed more than 1000 cases, and if we take into account the more experienced participants, the results are based on at least 16 968 stapes surgery experiences. While full consensus was reached by the expert panelists on 14 questions, agreement was reached by participants on only 2. The most striking difference between the panelists and attendees was regarding reparative granuloma.Conclusion: Even if a consensus was reached on some issues, controversies, especially the surgical technique, medical equipment and prostheses used are subjects to both discussion and development. Even the experts who come to present and share knowledge do not always agree. It is strongly recommended that clinicians follow all developments, compare their results with those of others, and use the techniques and materials with which they feel most comfortable for their patients.Cite this article as: Sönmez S, Serkan Orhan K, Baumgartner W, et al. Proceedings of the round table discussion on the Fifth International Symposium on Otosclerosis and Stapes Surgery. J Int Adv Otol. 2025, 21(2), 1839, doi: 10.5152/iao.2025.241839.
- 9 July 2025
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 21 (2) , 1-6
Open AccessProceedings of the Round Table Discussion on the Fifth International Symposium on Otosclerosis and Stapes Surgery
Background: Debates and research about otosclerosis and stapes surgery have continued since the time it was described, and there is still no consensus on many issues. The aim of this article is to report the controversies in the etiology, pathophysiology, diagnosis, imaging, treatment, and management of otosclerosis and address the points of consensus of experts.Methods: In the last session of the Fifth International Otosclerosis and Stapes Surgery Symposium held in Brussels, a round table meeting was held where controversial issues in otosclerosis and stapes surgery were discussed, and a survey was administered to all participants. Nine experienced panelists were interviewed by the moderator on stage, and 166 participants provided their answers interactively through the online voting system.Results: All of the panelists were experts in their field who had performed more than 1000 cases, and if we take into account the more experienced participants, the results are based on at least 16 968 stapes surgery experiences. While full consensus was reached by the expert panelists on 14 questions, agreement was reached by participants on only 2. The most striking difference between the panelists and attendees was regarding reparative granuloma.Conclusion: Even if a consensus was reached on some issues, controversies, especially the surgical technique, medical equipment and prostheses used are subjects to both discussion and development. Even the experts who come to present and share knowledge do not always agree. It is strongly recommended that clinicians follow all developments, compare their results with those of others, and use the techniques and materials with which they feel most comfortable for their patients.Cite this article as: Sönmez S, Serkan Orhan K, Baumgartner W, et al. Proceedings of the round table discussion on the Fifth International Symposium on Otosclerosis and Stapes Surgery. J Int Adv Otol. 2025, 21(2), 1839, doi: 10.5152/iao.2025.241839.
- 16 January 2025
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 145 (2) , 144-149
Analysis and long-term outcomes of spontaneous cerebrospinal otorrhea repair via the middle cranial fossa approach
The incidence of spontaneous CSF otorrhea is increasing and knowledge about treatment management is growing. To analyse the cases operated via the middle cranial fossa approach (MCFA) for spontaneous CSF otorrhea in our clinic and to evaluate the long-term surgical results in the light of the literature. Demographic data, presenting complaints, complications, hearing outcomes, recurrence rates and long-term success of patients operated with MCFA between 2012 and 2022 in our tertiary care centre were evaluated. The mean age of the 12 patients who met the inclusion criteria was 58.3 ± 13.4 years. Hearing loss and ear fullness in five patients and persistent otorrhea after ventilation tube insertion in three patients were the most common symptoms. The mean body mass index (BMI) was 35.03 ± 3.39. More than one defect was detected in seven patients. No perioperative or postoperative complications were observed in any patient. The mean airway hearing threshold (ASH)±SD was 40.6 ± 13 preoperatively and 24.4 ± 6.3 postoperatively, a statistically significant decrease (p = 0.003). The mean follow-up period was 80.8 ± 32.5 months and no recurrence was observed in any patient. Our experience and results support the use of MCFA in the repair of spontaneous CSF otorrhea as safe, highly successful, and beneficial.
- 16 January 2025
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 145 (2) , 144-149
Analysis and long-term outcomes of spontaneous cerebrospinal otorrhea repair via the middle cranial fossa approach
The incidence of spontaneous CSF otorrhea is increasing and knowledge about treatment management is growing. To analyse the cases operated via the middle cranial fossa approach (MCFA) for spontaneous CSF otorrhea in our clinic and to evaluate the long-term surgical results in the light of the literature. Demographic data, presenting complaints, complications, hearing outcomes, recurrence rates and long-term success of patients operated with MCFA between 2012 and 2022 in our tertiary care centre were evaluated. The mean age of the 12 patients who met the inclusion criteria was 58.3 ± 13.4 years. Hearing loss and ear fullness in five patients and persistent otorrhea after ventilation tube insertion in three patients were the most common symptoms. The mean body mass index (BMI) was 35.03 ± 3.39. More than one defect was detected in seven patients. No perioperative or postoperative complications were observed in any patient. The mean airway hearing threshold (ASH)±SD was 40.6 ± 13 preoperatively and 24.4 ± 6.3 postoperatively, a statistically significant decrease (p = 0.003). The mean follow-up period was 80.8 ± 32.5 months and no recurrence was observed in any patient. Our experience and results support the use of MCFA in the repair of spontaneous CSF otorrhea as safe, highly successful, and beneficial.